FindTrial
Sign In

Capecitabine 500Mg Oral Tablet

DRUG2 trials

Sponsors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Eye & ENT Hospital of Fudan University

Conditions

Metastatic Breast Cancerto Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma

Phase 2

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
NCT04389073
Cancer Institute and Hospital, Chinese Academy of Medical SciencesMetastatic Breast Cancer
Start: 2020-04-01End: 2023-12-31Target: 138Updated: 2022-02-25

Unknown Phase

A Prospective Exploratory Clinical Study of Metronomic Capecitabine as Adjuvant Therapy in Locoregionally Advanced Hypopharyngeal Carcinoma
RecruitingNCT05940441
Eye & ENT Hospital of Fudan Universityto Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
Start: 2023-07-01End: 2027-07-01Target: 74Updated: 2023-07-11

Related Papers

Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial.
2024-07-0515 citations
An immunogenic cell death-related signature for prediction of prognosis and response to immunotherapy in breast cancer
Chinese Medical Journal2023-11-212 citations